Board Meeting23 Oct 2026, 06:30 pm
Gujarat Kidney Board Meeting on Nov 4 to Approve Unaudited Results
AI Summary
Gujarat Kidney and Super Speciality Ltd has announced that its Board of Directors will convene on November 4, 2026. The primary agenda item is the consideration and approval of the unaudited standalone and consolidated financial results for the quarter ending September 30, 2026. In line with SEBI regulations, the trading window for designated persons and their immediate relatives has been closed from October 1st, 2026, and will reopen 48 hours after the announcement of these financial results.
Key Highlights
- Board meeting scheduled for November 4, 2026.
- To consider unaudited financial results for Q2 FY27.
- Results will be standalone and consolidated.
- Trading window closed from October 1, 2026.
- Window reopens 48 hours post-results announcement.
Price Impact
More from GKSL